NHS England has expanded access to the prostate cancer drug abiraterone after patient and charity campaigning. Previously ...
To say “no” would be to ignore the fact that we have been collecting patient-reported outcome measures for more than 10 years. This effort began in orthopedics as a small pilot project at my ...